Biologics Development and Manufacturing Testing: Technologies and Global Markets

Biologics Development and Manufacturing Testing: Technologies and Global Markets

Report Scope:

This report aims to provide a comprehensive study of the global market for biologics safety testing, both in terms of quantitative and qualitative data, to help develop business/growth strategies, assess the market landscape, analyze their position in the current marketplace, and make informed business decisions regarding biologics safety testing products and services. Biologics safety testing includes biosafety testing & characterization of raw materials, cell bank & virus seeds, unprocessed bulks/viral harvests, and drug substance/product.

This report segments the global biologics safety testing market by application, test application, testing technology, and region of operations. BCC Research analyses each market and its applications, regulatory environments, technology, market projections, and market share. Industry growth drivers, restraints, trends, and opportunities in the biological safety testing market are also discussed in detail. The report also provides information on the competitive landscape, elaborate company profiles, and the impact of COVID-19 on the biologics safety testing market.

Report Includes:

13 data tables and 16 additional tables

An up-to-date review and analysis of the global markets for biological safety testing and related technologies

Analyses of the global market trends, with market revenue data for 2019-2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2027

Discussion of market dynamics that impact the growth for biologics development and manufacturing testing, clinical applications, safety regulations, industry structure, and penetration of technologies within the biotech industry

Coverage of the technological, economic, and business considerations of global biological safety testing market, with analyses and growth forecasts through 2027

Estimation of the actual market size and revenue forecast for global biological safety testing market in USD million values, and corresponding market share analysis based on test type, application, technology, and region

Identification of the companies best positioned to meet the increasing demand for biological safety testing owing to their proprietary technologies, product launches, mergers and acquisitions, and other strategic advantages

Review of recent industry structure for biomarkers, R&D activities, and analysis of the competitive landscape based on recent developments and segmental revenues

Descriptive company profiles of the market leading players, including Catalent, Eurofins Scientific, Lonza, Merck, Thermo Fisher Scientific and WuXi AppTec

Companies Mentioned

AVANCE BIOSCIENCES
BSL Bioservice Scientific Laboratories Munich GmbH
CATALENT INC.
CHARLES RIVER LABORATORIES INTERNATIONAL INC.
CYTOVANCE BIOLOGICS
EUROFINS SCIENTIFIC
INTERTEK GROUP PLC
LABORATORY CORPORATION OF AMERICA HOLDINGS
LONZA
MERCK KGAA
SARTORIUS AG
SGS S.A.
THERMO FISHER SCIENTIFIC INC.
WUXI APPTEC